Acurx Pharmaceuticals Inc (ACXP)

Dec 18, 2024

ACXP stock touches 52-week low at $0.72 amid market challenges - Investing.com Canada

Dec 18, 2024

Dec 11, 2024

Acurx Pharmaceuticals to Present Latest Antibiotic Developments at 2025 Microcap Conference - StockTitan

Dec 11, 2024

Dec 11, 2024

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025January 30, 2025 - Eagle-Tribune

Dec 11, 2024

Dec 10, 2024

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024 - Kilgore News Herald

Dec 10, 2024

Dec 10, 2024

Acurx prepares for Phase 3 trials in C. difficile treatment By Investing.com - Investing.com Canada

Dec 10, 2024

Dec 09, 2024

Acurx prepares for Phase 3 trials in C. difficile treatment - Investing.com India

Dec 09, 2024

Dec 09, 2024

Acurx's Breakthrough CDI Antibiotic Advances Toward Global Phase 3 Trial Following FDA Green Light - StockTitan

Dec 09, 2024

Dec 04, 2024

ACXP stock touches 52-week low at $0.79 amid market challenges - Investing.com UK

Dec 04, 2024

Nov 29, 2024

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now - MSN

Nov 29, 2024

Nov 28, 2024

ACXP stock touches 52-week low at $1.01 amid market challenges - Investing.com Canada

Nov 28, 2024

Nov 22, 2024

MicroStrategy Now Has Copycats Buying Bitcoin as Prices Near $100,000 - Barron's

Nov 22, 2024

Nov 21, 2024

Nasdaq-Listed Acurx Invests $1M in Bitcoin—What’s Behind the Move? - Watcher Guru

Nov 21, 2024

Nov 20, 2024

Acurx Pharmaceuticals Allocates $1 Million to Bitcoin as Reserve Asset, Shares Slide 26% - Binance

Nov 20, 2024

Nov 20, 2024

Acurx Pharmaceuticals Shares Slide 17% After Disclosing Bitcoin Investment - MarketWatch

Nov 20, 2024

Nov 20, 2024

ACXP stock touches 52-week low at $1.5 amid market challenges - Investing.com UK

Nov 20, 2024

Nov 20, 2024

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset - Il Giornale d'Italia

Nov 20, 2024

Nov 20, 2024

Acurx Pharmaceuticals adopts Bitcoin as a reserve asset - TU News

Nov 20, 2024

Nov 20, 2024

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset | DigitalMore.co - Digital More

Nov 20, 2024

Nov 20, 2024

Acurx Pharmaceuticals allocates $1M for Bitcoin reserve - Investing.com

Nov 20, 2024

Nov 20, 2024

Acurx Pharmaceuticals allocates $1M for Bitcoin reserve By Investing.com - Investing.com UK

Nov 20, 2024

Nov 18, 2024

ACXPAcurx Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 18, 2024

Nov 18, 2024

Acurx Pharma Advances CDI Drug to Phase 3 Trials After Promising Clinical Data | ACXP Stock News - StockTitan

Nov 18, 2024

Nov 18, 2024

HC Wainwright Has Bullish Estimate for ACXP FY2024 Earnings - Defense World

Nov 18, 2024

Nov 18, 2024

Acurx Pharmaceuticals Reports Q3 2024 Financial Results and Business Update - Defense World

Nov 18, 2024

Nov 18, 2024

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Decline in Short Interest - Defense World

Nov 18, 2024

Nov 17, 2024

Acurx Pharmaceuticals’ (ACXP) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024

Nov 14, 2024

Keith Meister's Corvex opens fresh stakes in Dollar Tree, APD, exits CAE: top Q3 trades - MSN

Nov 14, 2024

Nov 14, 2024

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - MSN

Nov 14, 2024

Nov 14, 2024

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024

Nov 13, 2024

Acurx Pharmaceuticals Reports Promising Q3 2024 Results - TipRanks

Nov 13, 2024

Nov 13, 2024

Acurx Pharma Q3: New Patent Win & Trial Progress Despite Cash Decline to $5.8M | ACXP Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

Acurx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 11, 2024

Acurx Pharmaceuticals (ACXP) Set to Announce Quarterly Earnings on Wednesday - Defense World

Nov 11, 2024

Nov 05, 2024

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR's "Hack of the Week - Big News Network

Nov 05, 2024

Oct 31, 2024

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the... - Markets Insider

Oct 31, 2024

Oct 31, 2024

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week" - AccessWire

Oct 31, 2024

Oct 28, 2024

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH) - Quantisnow

Oct 28, 2024

Oct 26, 2024

AccreditedEvents.com Unveils Premier Lineup for November and December Investor Events - Big News Network

Oct 26, 2024

Oct 21, 2024

Acurx reports positive Phase 2 results for CDI treatment ibezapolstat - Investing.com India

Oct 21, 2024

Oct 21, 2024

Acurx reports positive Phase 2 results for CDI treatment ibezapolstat By Investing.com - Investing.com South Africa

Oct 21, 2024

Oct 21, 2024

Acurx Ready To Expand Pipeline With Anthrax Treatment (NASDAQ:ACXP) - Seeking Alpha

Oct 21, 2024

Oct 21, 2024

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference - StockTitan

Oct 21, 2024

Oct 17, 2024

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement - StockTitan

Oct 17, 2024